When Recursion launched in 2013, the fledgling biotech’s goal was to turn machine vision loose on images of cells, at scale, to better understand the biology of disease. Exscientia, founded the year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback